Torray LLC reduced its stake in shares of Cooper Companies Inc (NYSE:COO) by 5.7% in the 1st quarter, HoldingsChannel reports. The fund owned 79,669 shares of the medical device company’s stock after selling 4,791 shares during the quarter. Cooper Companies comprises 2.5% of Torray LLC’s holdings, making the stock its 4th largest position. Torray LLC’s holdings in Cooper Companies were worth $23,596,000 at the end of the most recent quarter.
A number of other institutional investors also recently added to or reduced their stakes in COO. Legal & General Group Plc grew its position in shares of Cooper Companies by 9.7% during the third quarter. Legal & General Group Plc now owns 255,020 shares of the medical device company’s stock worth $70,679,000 after acquiring an additional 22,461 shares during the last quarter. Vanguard Group Inc lifted its holdings in Cooper Companies by 0.6% in the third quarter. Vanguard Group Inc now owns 5,041,468 shares of the medical device company’s stock worth $1,397,243,000 after purchasing an additional 31,280 shares during the period. Meeder Asset Management Inc. lifted its holdings in Cooper Companies by 50.6% in the fourth quarter. Meeder Asset Management Inc. now owns 5,410 shares of the medical device company’s stock worth $1,377,000 after purchasing an additional 1,817 shares during the period. James Hambro & Partners acquired a new stake in Cooper Companies in the fourth quarter worth about $1,885,000. Finally, BTIM Corp. lifted its holdings in Cooper Companies by 9.0% in the fourth quarter. BTIM Corp. now owns 58,798 shares of the medical device company’s stock worth $14,965,000 after purchasing an additional 4,834 shares during the period.
In related news, SVP Agostino Ricupati sold 2,400 shares of the stock in a transaction that occurred on Friday, March 29th. The stock was sold at an average price of $296.13, for a total value of $710,712.00. Following the transaction, the senior vice president now owns 400 shares in the company, valued at $118,452. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Robert D. Auerbach sold 5,326 shares of the stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $300.00, for a total value of $1,597,800.00. Following the completion of the transaction, the insider now owns 4,954 shares in the company, valued at approximately $1,486,200. The disclosure for this sale can be found here. Insiders sold 87,030 shares of company stock worth $25,461,465 in the last 90 days. 1.70% of the stock is currently owned by corporate insiders.
Shares of COO traded up $2.25 during trading hours on Friday, reaching $293.91. The company’s stock had a trading volume of 4,896 shares, compared to its average volume of 265,500. Cooper Companies Inc has a 1-year low of $221.50 and a 1-year high of $302.36. The company has a market capitalization of $14.36 billion, a price-to-earnings ratio of 25.61, a P/E/G ratio of 2.25 and a beta of 0.85. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.27 and a quick ratio of 0.75.
Cooper Companies (NYSE:COO) last released its quarterly earnings data on Tuesday, March 5th. The medical device company reported $2.88 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.38. Cooper Companies had a return on equity of 17.56% and a net margin of 14.22%. The firm had revenue of $628.10 million for the quarter, compared to the consensus estimate of $618.50 million. Equities research analysts expect that Cooper Companies Inc will post 12.01 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Cooper Companies Inc (COO) Holdings Cut by Torray LLC” was first posted by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://weekherald.com/2019/05/17/cooper-companies-inc-coo-holdings-cut-by-torray-llc.html.
Cooper Companies Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
See Also: Why is cost of goods sold important?
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.